Complete Filing Data
SATIVUS TECH CORP. reported Net Income Loss of -$680.0 thousand for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SATIVUS TECH CORP. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$680.0K | -$324.0K | -$1.5M | -$3.9M | $7.6M | -$16.6M | -$5.1M | -$1.1M | -$71.9K | $16.4K |
| Revenue * | $36.3K | $137.5K | $110.2K | |||||||
| General And Administrative Expense | $271.0K | $562.0K | $660.0K | $1.6M | $456.0K | $273.0K | $2.1M | $330.0K | $113.8K | $31.7K |
| Operating Income Loss | -$958.0K | -$815.0K | -$1.3M | -$2.6M | -$563.0K | -$273.0K | -$4.9M | -$1.0M | -$75.2K | $20.0K |
| Nonoperating Income Expense | -$65.0K | $228.0K | -$480.0K | -$1.4M | -$1.4M | -$3.0M | ||||
| Research And Development Expense | $687.0K | $253.0K | $673.0K | $911.0K | $107.0K | $2.0M | $532.0K | |||
| Net Income Loss Attributable To Noncontrolling Interest | $340.0K | $263.0K | -$286.0K | |||||||
| Gross Profit | $12.5K | $48.0K | $53.0K | |||||||
| Cost Of Revenue | $21.3K | $80.7K | $52.6K | |||||||
| Operating Expenses | $44.2K | $123.1K | $33.0K | |||||||
| Selling And Marketing Expense | $815.0K | $187.0K | ||||||||
| Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net | -$33.4K | -$75.2K | $20.0K | |||||||
| Accrued Income Taxes Current | $320.00 | $3.6K | ||||||||
| Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest | -$1.5M | -$3.6M | $7.6M | |||||||
| Other Cost Of Operating Revenue | $8.9K | $4.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$266.0K | -$332.0K | -$1.0K | $2.1M | -$2.7M | $70.0K | $1.1M | -$996.0K | -$186.0K | -$732.0K | -$612.0K | $448.0K | -$588.0K | -$115.0K | -$2.2M | -$415.0K | $419.0K | $8.6M | -$3.1M | -$3.6M | -$1.7M | -$2.3M | -$950.0K | $801.00 | -$7.6K | $1.3K | -$4.2K | -$20.9K | -$13.2K | -$8.7K | -$28.0K | -$12.0K | $26.3K | |
| Revenue * | $310.0K | $383.0K | $14.5K | $30.0K | $16.5K | $16.0K | $9.0K | $0.00 | $24.3K | $61.1K | $41.1K | $31.4K | $41.7K | |||||||||||||||||||||
| General And Administrative Expense | $151.0K | $91.0K | $54.0K | $62.0K | $43.0K | $89.0K | $107.0K | $146.0K | $160.0K | $189.0K | $209.0K | $92.0K | $315.0K | $165.0K | $540.0K | $123.0K | $1.3M | $1.5M | $27.0K | $1.3M | $174.0K | $13.6K | $13.0K | $5.5K | $8.1K | $20.2K | $20.2K | $31.0K | $40.9K | $16.7K | $1.9K | |||
| Operating Income Loss | -$320.0K | -$213.0K | -$260.0K | -$155.0K | -$241.0K | -$215.0K | -$268.0K | -$53.0K | -$393.0K | -$407.0K | -$420.0K | -$157.0K | -$490.0K | -$320.0K | -$784.0K | -$125.0K | -$3.0M | -$3.0M | -$27.0K | -$2.0M | -$930.0K | -$6.8K | $2.0K | -$4.0K | -$20.9K | -$13.2K | -$8.7K | -$31.2K | -$12.0K | $26.3K | ||||
| Nonoperating Income Expense | -$83.0K | -$209.0K | $162.0K | $2.2M | -$2.5M | $203.0K | $1.3M | -$947.0K | $77.0K | -$435.0K | -$260.0K | $578.0K | -$98.0K | $205.0K | -$1.4M | -$290.0K | -$281.0K | -$327.0K | -$100.0K | -$572.0K | -$188.0K | -$235.0K | -$20.0K | |||||||||||
| Research And Development Expense | $169.0K | $122.0K | $206.0K | $93.0K | $198.0K | $126.0K | $161.0K | $233.0K | $218.0K | $211.0K | $65.0K | $125.0K | $142.0K | $176.0K | $2.0K | $1.2M | $1.1M | $489.0K | $582.0K | |||||||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | -$137.0K | -$90.0K | -$97.0K | -$51.0K | -$95.0K | -$82.0K | -$98.0K | -$4.0K | -$130.0K | -$110.0K | -$68.0K | -$58.0K | -$53.0K | |||||||||||||||||||||
| Gross Profit | -$252.0K | $183.0K | $6.0K | $16.7K | $6.4K | $8.5K | $4.5K | $0.00 | $7.5K | $22.7K | $13.6K | $4.7K | $28.2K | |||||||||||||||||||||
| Cost Of Revenue | $562.0K | $566.0K | $7.0K | $13.3K | $8.3K | $5.5K | $4.5K | $0.00 | $14.0K | $35.5K | $26.0K | $24.1K | $13.5K | |||||||||||||||||||||
| Operating Expenses | $13.7K | $15.2K | $13.2K | $6.5K | $8.5K | $20.9K | $20.7K | $31.4K | $44.8K | $16.7K | $1.9K | |||||||||||||||||||||||
| Selling And Marketing Expense | $0.00 | $0.00 | $50.0K | $13.0K | $68.0K | $253.0K | $228.0K | $264.0K | $174.0K | |||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net | -$7.6K | $1.3K | -$4.2K | -$20.9K | -$13.2K | -$8.7K | -$31.2K | -$12.0K | $26.3K | |||||||||||||||||||||||||
| Accrued Income Taxes Current | $320.00 | $320.00 | $320.00 | $320.00 | $320.00 | $320.00 | $320.00 | $0.00 | $320.00 | |||||||||||||||||||||||||
| Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest | -$732.0K | -$612.0K | $448.0K | -$530.0K | -$62.0K | -$2.2M | -$419.0K | |||||||||||||||||||||||||||
| Other Cost Of Operating Revenue | $2.0K | $0.00 | $2.8K | $2.9K | $1.5K | $2.7K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$2.3M | -$2.8M | -$2.5M | -$2.0M | -$10.7M | -$3.1M | -$368.0K | -$228.0K | $31.4K | |
| Cash And Cash Equivalents At Carrying Value | $176.0K | $810.0K | $866.0K | $411.0K | $10.0K | $744.0K | $11.0K | $18.5K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $810.0K | $866.0K | $411.0K | $2.0K | $1.0M | |||||
| Retained Earnings Accumulated Deficit | -$22.9M | -$22.6M | -$21.1M | -$17.5M | -$25.1M | -$8.5M | -$1.7M | -$55.5K | $16.4K | |
| Liabilities And Stockholders Equity | $1.4M | $1.2M | $1.0M | $418.0K | $2.0K | $12.0K | $1.4M | $14.8K | $36.0K | |
| Common Stock Value | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | $2.0K | $1.0K | $1.7K | $1.7K | |
| Assets Current | $1.1M | $901.0K | $963.0K | $418.0K | $2.0K | $12.0K | $1.3M | $14.0K | $33.5K | |
| Assets | $1.4M | $1.2M | $1.0M | $418.0K | $2.0K | $12.0K | $1.4M | $14.8K | $36.0K | |
| Property Plant And Equipment Net | $256.0K | $219.0K | $6.0K | $1.2M | $14.0K | $838.00 | $2.5K | |||
| Accounts Payable Current | $46.0K | $55.0K | $12.0K | $51.0K | $64.0K | $3.0K | $44.0K | |||
| Liabilities | $3.1M | $3.7M | $15.4K | $4.6K | ||||||
| Liabilities Current | $3.7M | $3.4M | $1.9M | $9.7M | $3.1M | $1.7M | $15.4K | $4.6K | ||
| Convertible Debt Current | $2.1M | $2.0M | $3.0M | $1.1M | $700.0K | $829.0K | ||||
| Other Liabilities Current | $110.0K | $100.0K | $22.0K | $1.3M | ||||||
| Minority Interest | $562.0K | $275.0K | $106.0K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$80.0K | -$634.0K | -$56.0K | $455.0K | $409.0K | |||||
| Assets Noncurrent | $271.0K | $249.0K | $52.0K | |||||||
| Other Assets Current | $77.0K | $7.0K | $2.0K | |||||||
| Repayments Of Convertible Debt | $0.00 | $126.0K | $278.0K | $74.0K | ||||||
| Operating Lease Right Of Use Asset | $0.00 | $15.0K | $30.0K | $46.0K | ||||||
| Finance Lease Principal Payments | $13.0K | $14.0K | $22.0K | $6.0K | ||||||
| Restricted Cash Current | $20.0K | $3.0K | $242.0K | |||||||
| Accounts Payable And Accrued Liabilities Current | $15.1K | $1.0K | ||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$272.0K | $733.0K | -$4.5K | $18.5K | ||||||
| Additional Paid In Capital Common Stock | $20.6M | $19.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q2 2015 | Q1 2015 | Q4 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$3.2M | -$3.2M | -$2.9M | -$2.9M | -$2.8M | -$4.9M | -$2.2M | -$1.7M | -$2.1M | -$3.2M | -$2.2M | -$3.1M | -$2.5M | -$2.0M | -$1.8M | -$2.0M | -$2.2M | -$1.8M | -$1.4M | -$1.9M | -$10.7M | -$3.4M | -$1.2M | -$1.5M | -$3.0M | -$2.1M | -$850.0K | -$24.0K | -$25.2K | -$21.1K | -$14.9K | -$1.7K | ||||||||
| Cash And Cash Equivalents At Carrying Value | $159.0K | $241.0K | $32.0K | $96.0K | $128.0K | $178.0K | $141.0K | $425.0K | $642.0K | $1.4M | $191.0K | $142.0K | $353.0K | $916.0K | $1.3M | $1.8M | $239.0K | $2.0K | $2.0K | $2.0K | $94.0K | $1.1M | $251.00 | $8.0K | $2.2K | $8.9K | $16.4K | $3.7K | $792.00 | $7.6K | $12.9K | $18.9K | $31.3K | $0.00 | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $159.0K | $241.0K | $32.0K | $96.0K | $128.0K | $178.0K | $141.0K | $176.0K | $425.0K | $642.0K | $1.4M | $191.0K | $142.0K | $366.0K | $916.0K | $1.3M | $1.8M | $245.0K | $1.3M | $111.0K | $607.0K | |||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$24.2M | -$23.9M | -$23.6M | -$23.6M | -$23.5M | -$25.6M | -$22.9M | -$22.7M | -$23.8M | -$22.8M | -$22.0M | -$21.2M | -$20.6M | -$20.2M | -$19.7M | -$18.5M | -$18.8M | -$15.7M | -$104.1K | -$95.7K | -$96.5K | -$79.3K | -$80.6K | -$76.4K | -$33.4K | -$20.2K | ||||||||||||||
| Liabilities And Stockholders Equity | $569.0K | $616.0K | $393.0K | $558.0K | $791.0K | $1.0M | $1.2M | $1.5M | $1.8M | $1.7M | $485.0K | $512.0K | $787.0K | $1.1M | $1.5M | $1.9M | $3.9M | $4.8M | $5.3K | $13.0K | $9.9K | $19.4K | $25.4K | $4.2K | $3.1K | $29.8K | ||||||||||||||
| Common Stock Value | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $2.0K | $2.0K | $293.00 | $293.00 | $293.00 | $293.00 | $293.00 | $293.00 | $1.7K | $1.7K | ||||||||||||||
| Assets Current | $231.0K | $269.0K | $61.0K | $131.0K | $323.0K | $516.0K | $880.0K | $1.2M | $1.5M | $1.5M | $242.0K | $260.0K | $564.0K | $1.1M | $1.5M | $1.9M | $2.7M | $3.6M | $5.3K | $13.0K | $9.9K | $19.4K | $25.4K | $3.7K | $1.8K | $28.1K | ||||||||||||||
| Assets | $569.0K | $616.0K | $393.0K | $558.0K | $791.0K | $1.0M | $1.2M | $1.5M | $1.8M | $1.7M | $485.0K | $512.0K | $787.0K | $1.1M | $1.5M | $1.9M | $3.9M | $4.8M | $5.3K | $13.0K | $9.9K | $19.4K | $25.4K | $4.2K | $3.1K | $29.8K | ||||||||||||||
| Property Plant And Equipment Net | $338.0K | $347.0K | $332.0K | $427.0K | $465.0K | $487.0K | $358.0K | $240.0K | $247.0K | $239.0K | $209.0K | $214.0K | $181.0K | $11.0K | $11.0K | $7.0K | $1.2M | $1.2M | $1.2M | $419.00 | $1.3K | $1.7K | ||||||||||||||||||
| Accounts Payable Current | $272.0K | $281.0K | $53.0K | $65.0K | $38.0K | $130.0K | $90.0K | $10.0K | $36.0K | $42.0K | $33.0K | $46.0K | $29.0K | $33.0K | $73.0K | $1.0K | $1.8M | $934.0K | ||||||||||||||||||||||
| Liabilities | $3.7M | $3.8M | $3.1M | $3.2M | $3.3M | $5.5M | $3.0M | $2.9M | $4.3M | $3.3M | $3.7M | $3.0M | $2.8M | $3.4M | $54.0K | $53.3K | $51.0K | $52.4K | $43.4K | $50.6K | $25.2K | $18.0K | $31.6K | |||||||||||||||||
| Liabilities Current | $3.6M | $3.0M | $2.7M | $2.8M | $2.4M | $2.3M | $7.0M | $5.8M | $54.0K | $53.3K | $51.0K | $43.4K | $50.6K | $25.2K | $18.0K | $31.6K | ||||||||||||||||||||||||
| Convertible Debt Current | $2.4M | $2.4M | $2.3M | $2.2M | $2.2M | $2.2M | $2.1M | $2.0M | $2.0M | $2.0M | $1.9M | $1.7M | $1.6M | |||||||||||||||||||||||||||
| Other Liabilities Current | $140.0K | $118.0K | $129.0K | $112.0K | $119.0K | $120.0K | $74.0K | $160.0K | $111.0K | $76.0K | $142.0K | $5.0K | $4.0K | $104.0K | ||||||||||||||||||||||||||
| Minority Interest | $141.0K | $80.0K | $161.0K | $251.0K | $343.0K | $391.0K | $483.0K | $577.0K | $667.0K | $666.0K | -$53.0K | $24.0K | $66.0K | $139.0K | $197.0K | $250.0K | ||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$64.0K | -$35.0K | $590.0K | -$520.0K | $1.4M | |||||||||||||||||||||||||||||||||||
| Assets Noncurrent | $338.0K | $347.0K | $332.0K | $427.0K | $468.0K | $494.0K | $369.0K | $259.0K | $269.0K | $265.0K | $243.0K | $252.0K | $223.0K | |||||||||||||||||||||||||||
| Other Assets Current | $11.0K | $316.0K | $290.0K | $11.0K | $34.0K | $49.0K | $75.0K | $85.0K | $40.0K | $107.0K | $198.0K | $171.0K | $147.0K | $68.0K | ||||||||||||||||||||||||||
| Repayments Of Convertible Debt | $0.00 | $121.0K | $75.0K | |||||||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $3.0K | $7.0K | $11.0K | $19.0K | $22.0K | $26.0K | $34.0K | $38.0K | $42.0K | |||||||||||||||||||||||||||||||
| Finance Lease Principal Payments | $0.00 | $5.0K | $5.0K | $8.0K | ||||||||||||||||||||||||||||||||||||
| Restricted Cash Current | $6.0K | $6.0K | $11.0K | $11.0K | $13.0K | $19.0K | $19.0K | $151.0K | $151.0K | $87.0K | ||||||||||||||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $24.8K | $24.9K | $23.3K | $25.5K | $17.2K | $25.2K | $24.9K | $18.0K | $31.2K | |||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $1.4M | -$10.2K | -$5.6K | $31.3K | ||||||||||||||||||||||||||||||||||||
| Additional Paid In Capital Common Stock | $21.0M | $20.7M | $20.7M | $20.7M | $20.7M | $20.6M | $20.6M | $20.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $19.0K | $156.0K | $267.0K | $1.3M | $171.0K | $134.0K | $948.0K | $3.5K | $0.00 | |
| Net Cash Provided By Used In Operating Activities | -$488.0K | -$932.0K | -$986.0K | -$1.4M | -$316.0K | -$7.0M | -$2.0M | $27.0K | -$40.9K | $7.3K |
| Net Cash Provided By Used In Financing Activities | $40.0K | $1.0M | $1.1M | $1.9M | $725.0K | $7.0M | $2.4M | $963.0K | $36.4K | $15.0K |
| Stock Issued During Period Value Share Based Compensation | $19.0K | $74.0K | $133.0K | $608.0K | $171.0K | |||||
| Net Cash Provided By Used In Investing Activities | $368.0K | -$721.0K | -$192.0K | -$27.0K | -$723.0K | -$257.0K | $0.00 | -$3.8K | ||
| Payments To Acquire Property Plant And Equipment | $269.0K | $79.0K | $206.0K | $7.0K | $906.0K | $15.0K | ||||
| Increase Decrease In Other Accounts Payable | $31.0K | -$48.0K | $50.0K | $10.0K | $100.0K | -$22.0K | $696.0K | $201.0K | ||
| Increase Decrease In Accounts Payable Trade | $19.0K | -$9.0K | $43.0K | -$13.0K | $61.0K | $389.0K | $26.0K | |||
| Proceeds From Issuance Of Warrants | $53.0K | $1.3M | $1.3M | $1.4M | ||||||
| Share Based Compensation To Employees And Nonemployee | $100.0K | $374.0K | $710.0K | |||||||
| Proceeds From Issuance Of Common Stock | $4.4M | $737.0K | $963.0K | $36.4K | $15.0K | |||||
| Increase Decrease In Receivables | -$289.0K | $228.0K | $8.0K | $70.0K | $7.0K | |||||
| Increase Decrease In Accounts Receivable | -$16.3K | $10.0K | $10.0K | |||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $10.3K | $14.1K | $1.0K | |||||||
| Depreciation Depletion And Amortization | $23.0K | $1.0K | $1.7K | $1.3K | ||||||
| Proceeds From Convertible Debt | $114.0K | $530.0K | $725.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2019 | Q2 2019 | Q4 2018 | Q4 2017 | Q4 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $0.00 | $9.0K | $74.0K | -$24.0K | $361.0K | $37.0K | $0.00 | $0.00 | $0.00 | $3.5K | $0.00 | $0.00 | |||||||||||||
| Net Cash Provided By Used In Operating Activities | -$482.0K | -$86.0K | -$150.0K | -$116.0K | -$417.0K | -$260.0K | -$538.0K | -$1.9M | -$414.00 | -$10.7K | -$5.6K | $16.3K | |||||||||||||
| Net Cash Provided By Used In Financing Activities | $54.0K | -$5.0K | $1.0M | -$83.0K | $1.9M | $2.4M | $500.00 | $0.00 | $15.0K | ||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $5.0K | $6.0K | $9.0K | $2.0K | $35.0K | $35.0K | $13.0K | $35.0K | $40.0K | $119.0K | $17.0K | $27.0K | $910.0K | $979.0K | $12.0K | ||||||||||
| Net Cash Provided By Used In Investing Activities | $32.0K | $86.0K | -$26.0K | -$177.0K | -$8.0K | -$100.0K | |||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $113.0K | $26.0K | $177.0K | $8.0K | $100.0K | |||||||||||||||||||
| Increase Decrease In Other Accounts Payable | $26.0K | $44.0K | -$86.0K | $32.0K | $4.0K | -$53.0K | |||||||||||||||||||
| Increase Decrease In Accounts Payable Trade | -$12.0K | $17.0K | -$13.0K | $17.0K | -$50.0K | -$189.0K | |||||||||||||||||||
| Proceeds From Issuance Of Warrants | $18.0K | $0.00 | $1.3M | $1.4M | $581.0K | ||||||||||||||||||||
| Share Based Compensation To Employees And Nonemployee | $19.0K | $26.0K | $39.0K | $50.0K | $127.0K | $147.0K | $16.0K | $27.0K | |||||||||||||||||
| Proceeds From Issuance Of Common Stock | $317.0K | $500.00 | $0.00 | $15.0K | |||||||||||||||||||||
| Increase Decrease In Receivables | -$23.0K | -$10.0K | $121.0K | $50.0K | |||||||||||||||||||||
| Increase Decrease In Accounts Receivable | $12.0K | $0.00 | $8.6K | $0.00 | $1.6K | $10.0K | |||||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$2.2K | $9.8K | $25.8K | $0.00 | |||||||||||||||||||||
| Depreciation Depletion And Amortization | $1.0K | $40.0K | $419.00 | $419.00 | $0.00 | ||||||||||||||||||||
| Proceeds From Convertible Debt | $36.0K | $0.00 | $530.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.16 | -$0.08 | -$0.36 | -$1.00 | $2.60 | -$0.86 | -$0.49 | -$0.11 | $0.00 | $0.00 |
| Common Stock Shares Issued | 4.2M | 4.2M | 4.2M | 3.2M | 20.5M | 16.2M | 10.4M | 17.3M | 17.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 4.2M | 4.2M | 4.2M | 3.2M | 20.5M | 16.2M | 10.4M | 17.3M | 17.0M | |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 3.6M | 2.9M | 19.3M | 10.6M | 9.7M | 17.3M | 17.0M | |||
| Weighted Average Number Of Shares Outstanding Basic | 4.2M | 4.2M | 4.2M | 3.6M | ||||||
| Earnings Per Share Basic | $-0.16 | $-0.08 | $-0.36 | $-1.00 | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 4.2M | 4.2M | 4.2M | 3.6M | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Authorized | 15.0M | 15.0M | ||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.05 | -$0.08 | $0.00 | $0.49 | -$0.66 | -$0.02 | $0.22 | -$0.24 | -$0.04 | -$0.17 | -$0.15 | $0.11 | -$0.01 | -$0.02 | -$0.03 | -$0.02 | -$0.01 | $0.36 | -$0.16 | -$0.18 | -$0.11 | -$0.22 | -$0.09 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Issued | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 41.0M | 35.0M | 32.3M | 20.4M | 20.0M | 2.9M | 2.9M | 2.9M | 2.9M | 2.9M | 2.9M | 17.3M | 17.3M | 347.5K | ||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Common Stock Shares Outstanding | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 41.0M | 35.0M | 32.3M | 20.4M | 20.0M | 2.9M | 2.9M | 2.9M | 2.9M | 2.9M | 2.9M | 17.3M | 17.3M | |||||||||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | |||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 38.0M | 32.6M | 31.8M | 26.6M | 28.9M | 22.7M | 20.0M | 19.8M | 15.3M | 10.6M | 10.6M | 2.9M | 2.9M | 2.9M | 2.9M | 8.2M | 17.3M | 17.3M | 17.0M | 17.0M | 17.0M | ||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 3.8M | 3.3M | 3.2M | ||||||||||||||||||||
| Earnings Per Share Basic | $-0.05 | $-0.08 | $0.00 | $0.49 | $-0.66 | $-0.02 | $0.26 | $-0.24 | $-0.04 | $-0.17 | $-0.15 | $0.11 | $-0.01 | $-0.02 | $-0.70 | ||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 4.8M | 4.2M | 4.2M | 4.2M | 4.2M | 4.2M | 3.8M | 3.3M | |||||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||||
| Preferred Stock Shares Authorized | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | ||||||||||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $18.6M | $15.4M | $14.4M | $5.4M | $1.3M | $16.7K | $13.3K | |||
| Depreciation | $116.0K | $60.0K | $38.0K | $6.0K | $838.00 | $1.7K | ||||
| Interest Paid Net | $0.00 | $126.0K | $175.0K | $74.0K | $35.0K | $48.0K | ||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $831.0K | $277.0K | $2.3M | |||||||
| Change In Fair Value Of Convertible Component In Convertible Loan | $117.0K | -$890.0K | $435.0K | $677.0K | ||||||
| Financial Expenses Related To Loans From Related Party | $320.0K | $2.2M | $949.0K | |||||||
| Other Short Term Borrowings | $0.00 | $13.0K | $32.0K | $20.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $20.6M | $20.6M | $19.8M | $18.9M | $18.7M | $18.6M | $18.4M | $17.7M | $16.3M | $15.5M | $14.6M | $55.1K | $55.1K | $55.1K | $55.1K | $55.1K | $55.1K | $16.7K | $16.7K | |||||||||
| Depreciation | $95.0K | $13.0K | $10.0K | $6.0K | $1.0K | $0.00 | $0.00 | $419.00 | $419.00 | $419.00 | $419.00 | |||||||||||||||||
| Interest Paid Net | $0.00 | $0.00 | $121.0K | $75.0K | $34.0K | |||||||||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $545.0K | $260.0K | $530.0K | $77.0K | $146.0K | $269.0K | $307.0K | $1.2M | ||||||||||||||||||||
| Change In Fair Value Of Convertible Component In Convertible Loan | -$141.0K | $1.0M | $900.0K | $23.0K | ||||||||||||||||||||||||
| Financial Expenses Related To Loans From Related Party | $45.0K | -$1.6M | $538.0K | |||||||||||||||||||||||||
| Other Short Term Borrowings | $0.00 | $4.0K | $6.0K | $12.0K | $27.0K | $30.0K |
Most recent annual filing with the SEC: March 31, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.